ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
Clinical trial NCT04561245 · COMPLETED
Trial details
- NCT number
- NCT04561245
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2021-10-29
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.